| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5900286 | Diabetes Research and Clinical Practice | 2012 | 6 Pages | 
Abstract
												In patients with diabetes and hypertriglyceridemia, a considerable discordance exists between non-HDL-C and Apo-B. Our data suggest a need for prospective studies to compare the relative merits of non-HDL-C and Apo-B targets in the assessment of cardiovascular risk.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Endocrinology
												
											Authors
												O.P. Ganda, C.G. Jumes, M.J. Abrahamson, M. Molla, 
											